ArticleBMC infectious diseases2016

Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm

Simon Mutembo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.